BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 31773012)

  • 21. Low contralateral failure rate with unilateral proton beam radiotherapy for oropharyngeal squamous cell carcinoma: A multi-institutional prospective study from the proton collaborative group.
    Mumaw DA; Hazy AJ; Vayntraub A; Quinn TJ; Salari K; Chang JH; Kalman N; Katz S; Urbanic J; Press RH; Thukral AD; Tsai H; Laramore GE; Molitoris J; Vargas C; Patel SH; Stevens C; Deraniyagala RL
    Radiother Oncol; 2024 Jan; 190():109977. PubMed ID: 37922991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pencil Beam Scanning (PBS) Intensity-Modulated Proton Therapy (IMPT) Chemoradiotherapy for Anal Canal Cancer-Single Institution Experience.
    Vítek P; Kubeš J; Vondráček V; Andrlik M; Navrátíl M; Zapletal R; Haas A; Dědečková K; Ondrová B; Grebenyuk A; Rosina J
    Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008349
    [No Abstract]   [Full Text] [Related]  

  • 23. Early and late side effects, dosimetric parameters and quality of life after proton beam therapy and IMRT for prostate cancer: a matched-pair analysis.
    Dutz A; Agolli L; Baumann M; Troost EGC; Krause M; Hölscher T; Löck S
    Acta Oncol; 2019 Jun; 58(6):916-925. PubMed ID: 30882264
    [No Abstract]   [Full Text] [Related]  

  • 24. Outcome After Modern Proton Beam Therapy in Childhood Craniopharyngioma: Results of the Prospective Registry Study KiProReg.
    Bischoff M; Khalil DA; Frisch S; Bäcker CM; Peters S; Friedrich C; Tippelt S; Kortmann RD; Bison B; Müller HL; Timmermann B
    Int J Radiat Oncol Biol Phys; 2024 Mar; ():. PubMed ID: 38492813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Particle Beam Radiation Therapy for Adenoid Cystic Carcinoma of the Nasal Cavity and Paranasal Sinuses.
    Hu W; Hu J; Huang Q; Gao J; Yang J; Qiu X; Kong L; Lu JJ
    Front Oncol; 2020; 10():572493. PubMed ID: 33102230
    [No Abstract]   [Full Text] [Related]  

  • 26. Proton Beam Therapy Combined with Intra-Arterial Infusion Chemotherapy for Stage IV Adenoid Cystic Carcinoma of the Base of the Tongue.
    Takayama K; Kato T; Nakamura T; Azami Y; Ono T; Suzuki M; Takada A; Yamaguchi H; Seto I; Nakasato T; Wada H; Kikuchi Y; Mitsudo K; Fuwa N; Murakami M
    Cancers (Basel); 2019 Sep; 11(10):. PubMed ID: 31546728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proton Beam Therapy for Children With Neuroblastoma: Experiences From the Prospective KiProReg Registry.
    Jazmati D; Butzer S; Hero B; Ahmad Khalil D; Merta J; Bäumer C; Plum G; Fuchs J; Koerber F; Steinmeier T; Peters S; Doyen J; Thole T; Schmidt M; Blase C; Tippelt S; Eggert A; Schwarz R; Simon T; Timmermann B
    Front Oncol; 2020; 10():617506. PubMed ID: 33552991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Outcomes of Patients With Recurrent Lung Cancer Reirradiated With Proton Therapy on the Proton Collaborative Group and University of Florida Proton Therapy Institute Prospective Registry Studies.
    Badiyan SN; Rutenberg MS; Hoppe BS; Mohindra P; Larson G; Hartsell WF; Tsai H; Zeng J; Rengan R; Glass E; Katz S; Vargas C; Feigenberg SJ; Simone CB
    Pract Radiat Oncol; 2019; 9(4):280-288. PubMed ID: 30802618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clinical results of proton beam therapy in patients with idiopathic pulmonary fibrosis: a single center experience.
    Ono T; Hareyama M; Nakamura T; Kimura K; Hayashi Y; Azami Y; Hirose K; Hatayama Y; Suzuki M; Wada H; Kikuchi Y; Nemoto K
    Radiat Oncol; 2016 Apr; 11():56. PubMed ID: 27090216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Skin Toxicity Profile of Photon Radiotherapy versus Proton Beam Therapy in Paediatric and Young Adult Patients with Sarcomas.
    Gaito S; Abravan A; Richardson J; Lowe M; Indelicato DJ; Burnet N; Smith E
    Clin Oncol (R Coll Radiol); 2021 Aug; 33(8):507-516. PubMed ID: 33820695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Multi-Institutional Experience of Proton Beam Therapy for Sinonasal Tumors.
    Yu NY; Gamez ME; Hartsell WF; Tsai HK; Laramore GE; Larson GL; Simone CB; Rossi C; Katz SR; Buras MR; Golafshar MA; Vargas CE; Patel SH
    Adv Radiat Oncol; 2019; 4(4):689-698. PubMed ID: 31673662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proton Therapy for Unresectable and Medically Inoperable Locally Advanced Pancreatic Cancer: Results From a Multi-Institutional Prospective Registry.
    Eckstein J; Choi JI; Lozano A; Ohri N; Press R; Hasan S; Kabarriti R; Chang J; Urbanic J; Durci M; Mohammed N; Stevens C; Tsai H; Apisarnthanarax S; Regine W; Vargas C; Nichols R; Herman J; Simone CB; Chhabra A
    Adv Radiat Oncol; 2023; 8(5):101250. PubMed ID: 37408677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proton therapy for thymic malignancies: multi-institutional patterns-of-care and early clinical outcomes from the proton collaborative group and the university of Florida prospective registries.
    Mercado CE; Hartsell WF; Simone CB; Tsai HK; Vargas CE; Zhu HJ; Henderson RH; Zeng J; Larson GL; Hoppe BS
    Acta Oncol; 2019 Jul; 58(7):1036-1040. PubMed ID: 30784340
    [No Abstract]   [Full Text] [Related]  

  • 34. Systematic assessment of clinical outcomes and toxicities of proton radiotherapy for reirradiation.
    Verma V; Rwigema JM; Malyapa RS; Regine WF; Simone CB
    Radiother Oncol; 2017 Oct; 125(1):21-30. PubMed ID: 28941560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-Term Clinical Safety of High-Dose Proton Radiation Therapy Delivered With Pencil Beam Scanning Technique for Extracranial Chordomas and Chondrosarcomas in Adult Patients: Clinical Evidence of Spinal Cord Tolerance.
    Stieb S; Snider JW; Placidi L; Kliebsch U; Lomax AJ; Schneider RA; Weber DC
    Int J Radiat Oncol Biol Phys; 2018 Jan; 100(1):218-225. PubMed ID: 29029887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dose escalation study of proton beam therapy with concurrent chemotherapy for stage III non-small cell lung cancer.
    Harada H; Fuji H; Ono A; Kenmotsu H; Naito T; Yamashita H; Asakura H; Nishimura T; Takahashi T; Murayama S
    Cancer Sci; 2016 Jul; 107(7):1018-21. PubMed ID: 27110950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multi-institutional Phase II study of proton beam therapy for organ-confined prostate cancer focusing on the incidence of late rectal toxicities.
    Nihei K; Ogino T; Onozawa M; Murayama S; Fuji H; Murakami M; Hishikawa Y
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):390-6. PubMed ID: 20832180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proton Beam Reirradiation for Recurrent Head and Neck Cancer: Multi-institutional Report on Feasibility and Early Outcomes.
    Romesser PB; Cahlon O; Scher ED; Hug EB; Sine K; DeSelm C; Fox JL; Mah D; Garg MK; Han-Chih Chang J; Lee NY
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):386-395. PubMed ID: 27084656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute toxicity of proton beam radiation for pediatric central nervous system malignancies.
    Suneja G; Poorvu PD; Hill-Kayser C; Lustig RA
    Pediatr Blood Cancer; 2013 Sep; 60(9):1431-6. PubMed ID: 23610011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Prospective Study of Proton Beam Reirradiation for Esophageal Cancer.
    Fernandes A; Berman AT; Mick R; Both S; Lelionis K; Lukens JN; Ben-Josef E; Metz JM; Plastaras JP
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):483-487. PubMed ID: 26847847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.